Skip Navigation


Rheumatology Advance Access originally published online on April 4, 2008
Rheumatology 2008 47(6):926-927; doi:10.1093/rheumatology/ken098
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/6/926    most recent
ken098v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cimmino, M. A.
Right arrow Articles by Parodi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cimmino, M. A.
Right arrow Articles by Parodi, M.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?

M. A. Cimmino, G. Zampogna and M. Parodi

Clinica Reumatologica, Dipartimento di Medicina Interna, Università di Genova, Italy

Correspondence to: M. A. Cimmino, Clinica Reumatologica, Dipartimento di Medicina Interna e Specialità Mediche, Viale Benedetto XV, 6, 16132 Genova, Italy. E-mail: cimmino@unige.it

The first 10% of the full text of this article appears below.

SIR, Blockmans et al. [1] showed that 31% of the patients with newly-diagnosed polymyalgia rheumatica (PMR) have moderate PET signs of vasculitis, especially of the subclavian arteries. Not surprisingly, more prominent vasculitic changes were found in 74% of the patients with GCA [2]. We have performed PET in steroid-resistant PMR patients with the aim of ascertaining whether undetected vasculitic changes could explain steroid resistance. Diagnosing large-vessel vasculitis should be relevant in this setting, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?